Literature DB >> 14769048

Evidence for an intermediate in tau filament formation.

Carmen N Chirita1, Jeff Kuret.   

Abstract

Alzheimer's disease is defined in part by the intraneuronal accumulation of filaments comprised of the microtubule-associated protein tau. In vitro, fibrillization of full-length, unphosphorylated recombinant tau can be induced under near-physiological conditions by treatment with various agents, including anionic surfactants. Here we examine the pathway through which anionic surfactants promote tau fibrillization using a combination of electron microscopy and fluorescence spectroscopy. Protein and surfactant first interacted in solution to form micelles, which then provided negatively charged surfaces that accumulated tau aggregates. Surface aggregation of tau protein was followed by the time-dependent appearance of a thioflavin S reactive intermediate that accumulated over a period of hours. The intermediate was unstable in the absence of anionic surfaces, suggesting it was not filamentous. Fibrillization proceeded after intermediate formation with classic nucleation-dependent kinetics, consisting of lag phase followed by the exponential increase in filament lengths, followed by an equilibrium phase reached in approximately 24 h. The pathway did not require protein insertion into the micelle hydrophobic core or conformational change arising from mixed micelle formation, because anionic microspheres constructed from impermeable polystyrene were capable of qualitatively reproducing all aspects of the fibrillization reaction. It is proposed that the progression from amorphous aggregation through intermediate formation and fibrillization may underlie the activity of other inducers such as hyperphosphorylation and may be operative in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769048     DOI: 10.1021/bi036034b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation.

Authors:  Hai-Li Zhu; Cristina Fernández; Jun-Bao Fan; Frank Shewmaker; Jie Chen; Allen P Minton; Yi Liang
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

3.  The role of annealing and fragmentation in human tau aggregation dynamics.

Authors:  Carol J Huseby; Ralf Bundschuh; Jeff Kuret
Journal:  J Biol Chem       Date:  2019-02-11       Impact factor: 5.157

4.  Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport.

Authors:  Chelsea T Tiernan; Benjamin Combs; Kristine Cox; Gerardo Morfini; Scott T Brady; Scott E Counts; Nicholas M Kanaan
Journal:  Exp Neurol       Date:  2016-06-30       Impact factor: 5.330

5.  Differentiating Alzheimer disease-associated aggregates with small molecules.

Authors:  Nicolette S Honson; Ronald L Johnson; Wenwei Huang; James Inglese; Christopher P Austin; Jeff Kuret
Journal:  Neurobiol Dis       Date:  2007-07-28       Impact factor: 5.996

Review 6.  A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence.

Authors:  Abhinav Nath; Elizabeth Rhoades
Journal:  FEBS Lett       Date:  2013-03-01       Impact factor: 4.124

Review 7.  Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

Authors:  Jennifer N Rauch; Steven H Olson; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

8.  Ligand electronic properties modulate tau filament binding site density.

Authors:  Katryna Cisek; Jordan R Jensen; Nicolette S Honson; Kelsey N Schafer; Grace L Cooper; Jeff Kuret
Journal:  Biophys Chem       Date:  2012-09-11       Impact factor: 2.352

Review 9.  The last tangle of tau.

Authors:  Huiping Ding; Gail V W Johnson
Journal:  J Alzheimers Dis       Date:  2008-08       Impact factor: 4.472

10.  Potent inhibition of tau fibrillization with a multivalent ligand.

Authors:  Nicolette S Honson; Jordan R Jensen; Michael V Darby; Jeff Kuret
Journal:  Biochem Biophys Res Commun       Date:  2007-09-06       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.